Volumen 6, Asunto 4 (2009)
Artículo de revisión
Lifestyle management: preventing Type 2 diabetes and cardiovascular complications
Rebecca S Stiegler, Paul Z Zimmet, Adrian J Cameron and Jonathan E Shaw
Artículo de investigación
Chemotherapy-induced nausea and vomiting in Portugal: incidence versus healthcare provider estimations and effect on quality of life
Jose Dinis, Tami Wisniewski, Antonio Moreira, Joao Raposo, Larry Ma & Thomas A Burke
Artículo de revisión
Glycemic control and cardiovascular disease in a high-risk chronic kidney disease population
Rachandeep Singh, Ravi Nistala, Samy I McFarlane and Adam Whaley-Connell
Editorial
Does normalization of blood glucose reduce the rate of cardiovascular events?
Sabreena Basu
Artículo de revisión
Novel strategies and future landmarks in the treatment of irritable bowel syndrome
Richard Roka, Krisztina Gecse and Tibor Wittmann
Aspectos destacados de investigación
Fenofibrate effects on cardiovascular outcomes in patients with diabetes and metabolic syndrome
Brian K Irons
Evaluación de medicamentos
Pemetrexed in the treatment of malignant pleural mesothelioma
Michael D Peake
Evaluación de medicamentos
Ofatumumab for the treatment of chronic lymphocytic leukemia
Tadeusz Robak
Artículo de revisión
Treatment of hypertension in the diabetic patient
Amgad N Makaryus and Samy I McFarlane
Reporte especial
Pharmacogenomics and the prevention of vascular complications in diabetes mellitus
Dan Farbstein and Andrew P Levy
Evaluación de medicamentos
Lapatinib in the management of breast cancer
Peter S Hall, Jaishree Bhosle and David A Cameron
Reporte de un caso
Efficacy of clobazam monotherapy in three cases of symptomatic localization-related epilepsy in children
Toshiyuki Iwasaki, Yutaka Nonoda, Kenji Takei, Nozomi Hosoda and Masahiro Ishii
Prefacio
Diabetes and cardiovascular disease: time for individualized risk reduction
Samy I McFarlane and James R Sowers
Evaluación de medicamentos
Colesevelam hydrochloride: a bile acid sequestrant for glycemic control and treatment of dyslipidemia in Type 2 diabetes mellitus
Prasanth N Surampudi, Prathima Nagireddy and Vivian A Fonseca
Editorial
Will computational simulation in congenital heart disease ever make it out of the engineering lab and into the clinic?
Alison L Marsden and Jeffrey A Feinstein
Artículo de revisión
Hyperglycemia, dyslipidemia and hypertension in older people with diabetes: the benefits of cardiovascular risk reduction
Siobhan HM Brown and Ahmed H Abdelhafiz
